Purchase Order 75N91024P00590
- Not listed
- This is a $18,450 firm fixed-price purchase order awarded by the National Cancer Institute (NCI) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation. The contract is for a service agreement with a completion date of January 9, 2026. Miltenyi Biotec, which is a foreign-owned, for-profit manufacturer, has extensive experience as a prime...
- This is a $19,325.00 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer of scientific instruments, reagents, and services for biomedical research and cell therapy development. The contract is for the provision of specialized scientific equipment and associated maintenance services,...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer of goods. The $211,830 contract is for the provision of Miltenyi's biotechnology products and services to support biomedical research and cell and gene therapy, including instruments, reagents, kits, and antibodies. The award does not have a set-aside...
- This is a $31,160 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) in Pittsburgh to Miltenyi Biotec, Inc., a global biotechnology company. The contract, awarded on August 21, 2024, is for the delivery of laboratory equipment with a completion date of August 21, 2024. Miltenyi Biotec is a foreign-owned, for-profit manufacturer that provides specialized scientific instruments, reagents, and services to government agencies. The company has extensive...
- This $4,881 firm fixed-price purchase order was awarded to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research and cell therapy development. The award is for the delivery of lab equipment to the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). Miltenyi Biotec has extensive experience as a prime contractor for federal...
- This is a $4,250 fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer of biotechnology products. The contract is not set aside and runs through May 2011. Miltenyi Biotec provides specialized scientific instruments, reagents, and services to support biomedical research, particularly in areas such as cancer, immunology, and infectious diseases. Key deliverables under this award...
- This is a $13,092 firm fixed-price purchase order awarded to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer, by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases. The contract is for a SERVICE CONTRACT FOR AUTOMACS PRO SEPARATOR with a completion date of December 14, 2020. Miltenyi Biotec, a global biotechnology company, has served as a prime contractor on numerous contracts with federal agencies,...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer of biotechnology products and services. The $22,175 contract provides a one-year period of performance for the NIH's National Institute of Allergy and Infectious Diseases to acquire Miltenyi's MACSQuant flow cytometer analyzer and AutoMACS Pro cell separator. These products and associated...
- This is a $14,781 fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc. The contract is for the supply of specialized biotechnology products and services, including cell separation and analysis equipment, reagents, and consumables. Miltenyi Biotec is a global biotechnology company that frequently provides equipment and supplies to federal agencies like the NIH,...
- This is a $23,230 firm fixed-price purchase order contract awarded to Miltenyi Biotec, Inc., a global biotechnology company, by the National Institute on Aging, a civilian federal agency. The contract delivers specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation, including flow cytometers, cell sorters, tissue dissociators, automated cell separation systems, and associated consumables. Miltenyi Biotec has an...
This is a $24,999.00 firm fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer of specialized laboratory equipment and reagents. The contract is for the delivery of unspecified laboratory equipment, with a period of performance through September 7, 2024. While not awarded under a set-aside program, Miltenyi Biotec has extensive experience as a prime contractor for the NCI and other federal agencies, including the Department of Veterans Affairs, Department of Defense, and Centers for Disease Control and Prevention. The company is a leading provider of cell isolation, analysis, and processing technologies that support biomedical research and clinical trials, particularly in areas such as cancer, immunology, and infectious diseases. This award is likely part of Miltenyi Biotec's existing indefinite delivery contract with the NCI Clinical Center, valued at $2.3 million, which ensures the availability of FDA-approved, clinical-grade reagents and supplies for the NCI's cell therapy manufacturing operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.0k | 8/8/24 |